Example: Heart Attack
Search clinical trials for: Dose decrease
Total 7779 results
-
NCT05377580CompletedUlcerative Colitis (UC)
-
NCT07522242Recruiting
-
NCT06598462Active, not recruitingEosinophilic Esophagitis (EoE)
-
NCT03723798Completed
-
NCT04453800Completed
-
NCT02310802Completed
-
NCT04167059Unknown
-
NCT02012816Completed
-
NCT06372535Not yet recruiting
-
NCT06602583Not yet recruitingCoronary Arterial Disease (CAD)
-
-
NCT07412015Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
NCT05875961CompletedInfections | Virus Diseases | Respiratory Tract Infections | Influenza, Human | Infection Viral
-
NCT04653766Completed
-
NCT05223660CompletedPharmacokinetics | Healthy Adult Subjects | Safety and Tolerability
-
NCT02038764CompletedDiabetes Mellitus, Type 1
-
NCT04871620Recruiting
-
NCT05159076Completed
-
NCT05900739CompletedFruit and Vegetable Consumption
-
NCT01920490CompletedMajor Depressive Disorder
-
-
NCT01661244Completed
-
NCT00121745Terminated
-
NCT06559007Completed
-
NCT01900522Terminated
-
NCT07463196Recruiting
-
NCT07519265Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
NCT03346122Completed
-
NCT05677438Completed
-
-
NCT06993155Recruiting
-
NCT06324344TerminatedPain | Neuropathy | Chemotherapy-induced Peripheral Neuropathy
-
NCT05264038Completed
-
NCT01540669TerminatedFunctional Constipation
-
NCT05202886RecruitingBrain Death | Liver Steatosis
-
NCT06905795Active, not recruitingChildren | MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
-
NCT03413657Completed
-
NCT06155084RecruitingMetastatic Castration-resistant Prostate Cancer
-
NCT02388152Terminated
-
NCT00827632CompletedOvarian Suppression
-
NCT02980705TerminatedActive Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis
-
NCT06184542RecruitingPertussis | Tetanus | Diphtheria
-
NCT07035249RecruitingSolid Tumors | HNSCC | DCSZ11
-
NCT05540327Active, not recruitingSystemic Lupus Erythematosus
-
NCT05162586CompletedSystemic Lupus Erythematosus
-
NCT01959165CompletedUlcerative Colitis
-
NCT07358585Not yet recruiting
-
NCT02579759CompletedPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)Charcot-Marie-Tooth Disease Type 1A